These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11350951)

  • 1. Transcriptional repression by p53 through direct binding to a novel DNA element.
    Johnson RA; Ince TA; Scotto KW
    J Biol Chem; 2001 Jul; 276(29):27716-20. PubMed ID: 11350951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
    Suzuki T; Uchida-Toita M; Yoshida M
    Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.
    Sampath J; Sun D; Kidd VJ; Grenet J; Gandhi A; Shapiro LH; Wang Q; Zambetti GP; Schuetz JD
    J Biol Chem; 2001 Oct; 276(42):39359-67. PubMed ID: 11483599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.
    Farmer G; Friedlander P; Colgan J; Manley JL; Prives C
    Nucleic Acids Res; 1996 Nov; 24(21):4281-8. PubMed ID: 8932384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation.
    Zhan M; Yu D; Liu J; Glazer RI; Hannay J; Pollock RE
    J Biol Chem; 2005 Feb; 280(6):4825-33. PubMed ID: 15563462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53.
    Ori A; Zauberman A; Doitsh G; Paran N; Oren M; Shaul Y
    EMBO J; 1998 Jan; 17(2):544-53. PubMed ID: 9430645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells.
    Mathieu MC; Lapierre I; Brault K; Raymond M
    J Biol Chem; 2001 Feb; 276(7):4819-27. PubMed ID: 11096091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53.
    St Clair S; Manfredi JJ
    Cell Cycle; 2006 Apr; 5(7):709-13. PubMed ID: 16582636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein p53 modulates transcription from a promoter containing its binding site in a concentration-dependent manner.
    Kristjuhan A; Maimets T
    Eur J Biochem; 1995 Dec; 234(3):827-31. PubMed ID: 8575441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
    Li B; Lee MY
    J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
    Marks J; Saifudeen Z; Dipp S; El-Dahr SS
    J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent down-regulation of telomerase is mediated by p21waf1.
    Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
    J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding.
    Gridasova AA; Henry RW
    Mol Cell Biol; 2005 Apr; 25(8):3247-60. PubMed ID: 15798209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.
    St Clair S; Giono L; Varmeh-Ziaie S; Resnick-Silverman L; Liu WJ; Padi A; Dastidar J; DaCosta A; Mattia M; Manfredi JJ
    Mol Cell; 2004 Dec; 16(5):725-36. PubMed ID: 15574328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 amino acids 339-346 represent the minimal p53 repression domain.
    Hong TM; Chen JJ; Peck K; Yang PC; Wu CW
    J Biol Chem; 2001 Jan; 276(2):1510-5. PubMed ID: 11007800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
    Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
    Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.